住院儿童抗真菌和抗病毒药物使用的变异性
Variability in Antifungal and Antiviral Use in Hospitalized Children.
作者信息
Goldman Jennifer L, Ross Rachael K, Lee Brian R, Newland Jason G, Hersh Adam L, Kronman Matthew P, Gerber Jeffrey S
机构信息
1Children's Mercy Hospitals & Clinic,Kansas City,Missouri.
2The Children's Hospital of Philadelphia,Philadelphia,Pennsylvania.
出版信息
Infect Control Hosp Epidemiol. 2017 Jun;38(6):743-746. doi: 10.1017/ice.2017.40. Epub 2017 Mar 15.
Abstract
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children's hospitals. Antifungal and antiviral days of therapy varied across hospitals. Benchmarking antifungal and antiviral use and developing antimicrobial stewardship strategies to optimize use of these high cost agents is needed. Infect Control Hosp Epidemiol 2017;38:743-746.
摘要
我们分析了独立儿童医院中高危儿童的抗真菌和抗病毒药物处方情况。各医院的抗真菌和抗病毒治疗天数有所不同。需要对抗真菌和抗病毒药物的使用进行基准对比，并制定抗菌药物管理策略，以优化这些高成本药物的使用。《感染控制与医院流行病学》2017年；38卷：743 - 746页 。
相似文献
1
Variability in Antifungal and Antiviral Use in Hospitalized Children.
Infect Control Hosp Epidemiol. 2017 Jun;38(6):743-746. doi: 10.1017/ice.2017.40. Epub 2017 Mar 15.
2
Identifying targets for antimicrobial stewardship in children's hospitals.
Infect Control Hosp Epidemiol. 2013 Dec;34(12):1252-8. doi: 10.1086/673982. Epub 2013 Oct 24.
3
Posaconazole Administration in Hospitalized Children in the United States.
J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):481-484. doi: 10.1093/jpids/piy119.
4
Cost of antimicrobial therapy across US children's hospitals.
Infect Control Hosp Epidemiol. 2015 Oct;36(10):1242-4. doi: 10.1017/ice.2015.159. Epub 2015 Jul 13.
5
Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study.
BMC Infect Dis. 2021 Jan 22;21(1):100. doi: 10.1186/s12879-021-05774-9.
6
7
Antimicrobial stewardship programs in freestanding children's hospitals.
Pediatrics. 2015 Jan;135(1):33-9. doi: 10.1542/peds.2014-2579. Epub 2014 Dec 8.
8
[Assessment of adherence to Afssaps guidelines for the prescription of antifungals in pediatric hemato-oncology].
Med Mal Infect. 2011 Jan;41(1):25-32. doi: 10.1016/j.medmal.2010.09.012. Epub 2010 Nov 17.
9
Pharmaceutical prescribing for children. Part 4. Antifungal and antiviral therapy.
Prim Dent Care. 2006 Apr;13(2):59-61. doi: 10.1308/135576106776337931.
10
Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.
Antimicrob Agents Chemother. 2015 Feb;59(2):782-9. doi: 10.1128/AAC.04109-14. Epub 2014 Nov 17.
引用本文的文献
1
Antifungal stewardship in practice: Insights from a prospective audit and feedback program.
Infect Control Hosp Epidemiol. 2023 Dec;44(12):2017-2021. doi: 10.1017/ice.2023.129. Epub 2023 Jun 29.
2
Characteristics of antifungal utilization for hospitalized children in the United States.
Antimicrob Steward Healthc Epidemiol. 2022 Dec 2;2(1):e190. doi: 10.1017/ash.2022.338. eCollection 2022.
3
Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America.
BMC Infect Dis. 2018 Oct 3;18(1):501. doi: 10.1186/s12879-018-3410-4.
4
Pediatric Antimicrobial Stewardship: State of the Art.
Curr Infect Dis Rep. 2018 Aug 1;20(10):39. doi: 10.1007/s11908-018-0644-7.
5
Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.
J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):241-248. doi: 10.1093/jpids/pix104.
本文引用的文献
1
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
2
Cost of antimicrobial therapy across US children's hospitals.
Infect Control Hosp Epidemiol. 2015 Oct;36(10):1242-4. doi: 10.1017/ice.2015.159. Epub 2015 Jul 13.
3
Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.
J Antimicrob Chemother. 2015;70(6):1908-11. doi: 10.1093/jac/dkv040. Epub 2015 Feb 25.
4
Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.
Antimicrob Agents Chemother. 2015 Feb;59(2):782-9. doi: 10.1128/AAC.04109-14. Epub 2014 Nov 17.
5
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Lancet Oncol. 2014 Jul;15(8):e327-40. doi: 10.1016/S1470-2045(14)70017-8.
6
Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed.
J Antimicrob Chemother. 2014 Jul;69(7):1993-9. doi: 10.1093/jac/dku053. Epub 2014 Mar 21.
7
Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States.
Infect Control Hosp Epidemiol. 2014 Mar;35(3):265-71. doi: 10.1086/675277. Epub 2014 Jan 24.
8
Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia.
Leuk Lymphoma. 2013 Aug;54(8):1633-9. doi: 10.3109/10428194.2012.750722. Epub 2012 Dec 26.
9
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2011 Feb 15;52(4):427-31. doi: 10.1093/cid/ciq147. Epub 2011 Jan 4.
10
Pediatric antifungal utilization: new drugs, new trends.
Pediatr Infect Dis J. 2008 Dec;27(12):1083-8. doi: 10.1097/INF.0b013e31817eeee5.
Zotero 插件